Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Natural circulating antibodies last for at least seven months in children infected with COVID-19

18 Mar 2022
Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

18 Mar 2022
SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

18 Mar 2022
Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

18 Mar 2022
Study shows small airways disease with the presence of air trapping is a long-lasting sequelae of SARS-CoV-2 infection

Study shows small airways disease with the presence of air trapping is a long-lasting sequelae of SARS-CoV-2 infection

18 Mar 2022
Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

18 Mar 2022
Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

17 Mar 2022
Why does the SARS-CoV-2 Omicron variant escape immunity?

Why does the SARS-CoV-2 Omicron variant escape immunity?

17 Mar 2022
Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

17 Mar 2022
BNT162b2 booster vaccination induces robust humoral and cellular immune responses

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

17 Mar 2022
Two clever human antibodies can target Ebola and Sudan virus

Two clever human antibodies can target Ebola and Sudan virus

17 Mar 2022
It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

17 Mar 2022
Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

17 Mar 2022
Clinical utility of Roche assays determined utilizing samples from participants enrolled in a phase 2 trial of the mRNA-1273 vaccine

Clinical utility of Roche assays determined utilizing samples from participants enrolled in a phase 2 trial of the mRNA-1273 vaccine

17 Mar 2022
Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

17 Mar 2022
Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

17 Mar 2022
Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

17 Mar 2022
The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

17 Mar 2022
The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

17 Mar 2022
Frail and older males more vulnerable to COVID-19 than females

Frail and older males more vulnerable to COVID-19 than females

17 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback